The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study
Crossref DOI link: https://doi.org/10.1007/s11060-014-1522-2
Published Online: 2014-07-15
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vranceanu, Ana-Maria
Merker, Vanessa L.
Plotkin, Scott R.
Park, Elyse R.
Text and Data Mining valid from 2014-07-15